IQVIA Holdings Inc. (IQV)

Healthcare · Diagnostics Research · NYSE

S&P 500

IQVIA Holdings Inc. (IQV) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $44.46B, a trailing price-to-earnings ratio of 21.7 and a free-cash-flow yield of 4.4%. Over the most recent reported fiscal year, revenue grew 5.9% and free cash flow per share grew 2.6%.

Market cap	$44.46B
Trailing P/E	21.7
FCF yield	4.4%
Revenue growth (YoY)	+5.9%
EPS growth (YoY)	+7.1%
FCF/share growth (YoY)	+2.6%
Exchange	NYSE
Sector	Healthcare
Industry	Diagnostics Research

Explore live IQV data on Nama Insights →

Recent Congressional trades

IQVIA Holdings Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Kevin Hern	House	Sell	$50,001 - $100,000	Apr 3, 2026
Rob Bresnahan	House	Sell	$1,001 - $15,000	May 31, 2025
Rob Bresnahan	House	Buy	$15,001 - $50,000	May 8, 2025
Rob Bresnahan	House	Sell	$1,001 - $15,000	Mar 27, 2025
John F Reed	Senate	Sell	$1,001 - $15,000	—
John F Reed	Senate	Sell	$1,001 - $15,000	—
John F Reed	Senate	Sell	$1,001 - $15,000	—